The SURPASS trials demonstrated significant HbA1c reduction in type 2 diabetes patients
No reputable provider should supply prescription weight loss treatment without going through that process, and at Pharmacy Planet we take that seriously.
Ideal candidates for tirzepatide are individuals struggling with weight management challenges, particularly those diagnosed with type 2 diabetes
In addition, you must meet one of the three clinical criteria set by CMS, measured at the time you start GLP-1 therapy: BMI of 35 or higher (and age 18 or older), or BMI of 30 or higher (and age 18 or older), plus one of the following: heart failure with preserved ejection fraction, uncontrolled high blood pressure (systolic above 140 or diastolic above 90 despite treatment with two blood pressure medications), or chronic kidney disease stage 3a or above, or BMI of 27 or higher (and age 18 or older), plus one of the following: prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease If you take a GLP-1 for another condition, the Bridge is not for you
Potential growth area